|
LE Magazine October 1999
Osteoarthritis
& Rheumatoid Arthritis
Continued from Article Osteoarthritis & Rheumatoid
Arthritis
Bates CJ: Proline and hydroxyproline excretion
and vitamin C status in elderly human subjects. Clin Sci
Mol Med (1977) 52: 535-43.
Belluzzi A et al.: Effect of an enteric-coated
fish-oil preparation on relapses in Crohn's disease. NEJM
(1996) 334: 1557-1560.
Bertolini DR et al.: Stimulation of bone
resorption and inhibition of bone formation in vitro by human
tumor necrosis factor. Nature (1986) 319: 516-18.
Birkedal-Hansen H et al.: Matrix metalloproteinases:
A review. Crit Rev Oral Biol Med (1993) 4: 197-250.
Bondeson J et al.: Defining therapeutic
targets by using adenovirus: Blocking NK-kB inhibits both
inflammatory and destructive mechanisms in rheumatoid synovium
but spares anti-inflammatory mediators. Proc Natl Acad
Sci USA (1999) 96: 5668-5673.
Bourgeois P et al.: Efficacy and tolerability
of chondroitin sulfate 1200mg/day vs placebo. Osteoarth
Cartil (1998) 6, Suppl. A: 25-30.
Brooks PM et al.: NSAID and osteoarthritis
- help or hindrance. J Rheumatol (1982) 9: 3-5.
Bucsi L et al.: Efficacy and tolerability
of oral chondroitin sulfate as a slow-acting drug for osteoarthritis
(SYSADOA) in the treatment of knee osteoarthritis. Osteoarth
Cartil (1998) 6, Suppl. A: 31-36.
Caugey GE et al.: The effect on human tumor
necrosis factor-a and interleukin-1b production of diets enriched
in n-3 fatty acids from vegetable oil or fish oil. Am
J Clin Nutr (1996) 63: 116-22.
Chrubasik S et al.: Evidence for antirheumatic
effectiveness of Herba Urticae dioicae in acute arthritis:
a pilot study. Phytomedicine (1997) 4: 105-108.
Engstrom K et al.: Effect of Low-dose aspirin
in combination with Stable Fish Oil on Eicosanoids. EPA and
Eicosanoids. Prost Leukotr Ess Fat Acid (1997) 57:
229.
Feldmann M et al.: Anti-tumor necrosis
factor-a therapy of rheumatoid arthritis. Adv Immunol
(1997) 84: 283-350.
Feldmann M et al.: Role of cytokines in
rheumatoid arthritis. Annu Rev Immunol (1996) 14:
397-440.
Flynn DL et al.: Inhibition of human neutrophil
5-lipoxygenase activity by gingerdione, shogaol, capsaicin
and related pungent compounds. Prost Leukotr Med
(1986) 24: 195-198.
Hardingham T: Chondroitin sulfate and joint
disease. Osteoarth Cartil (1998) 6, Suppl. A: 3-5.
Hill PA et al.: The effects of selective
inhibitors of matrix metalloproteinases on bone resorption
and the identification of MMPs and TIMP-1 in isolated osteoclasts.
J Cell Sci (1994) 107: 3055-3064.
James MJ et al.: Dietary n-3 fatty acids
and therapy for rheumatoid arthritis. Semin Arthritis
Rheum (1997) 27: 85-97.
Kiuchi F et al.: Inhibition of prostaglandin
and leucotriene biosynthesis by gingerols and diarylheptanoids.
Chem Pharm Bull (1992) 40: 387-391.
Jue DM et al.: Nuclear factor kb (NF-kb)
pathway as a therapeutic target in rheumatoid arthritis. J
Kor Med Sci (1999) 14: 231-238.
Kremer JM et al.: Clinical studies of n-3
fatty acids supplementation in patients with rheumatoid arthritis.
Rheum Dis Clinics (1992) 17: 391-402.
Kremer JM et al.: Effects of manipulation
of dietary fatty acids on clinical manifestations of rheumatoid
arthritis. Lancet (1985) 1(8422): 184-187.
Kremer JM et al.: Fish-oil fatty acid supplementation
in active rheumatoid arthritis: a double-blinded, controlled
crossover study. Ann Int Med (1987) 106: 497-503.
Needleman P et al.: Triene prostaglandins:
prostacyclin and thromboxane biosynthesis and unique biological
properties. Proc Natl Acad Sci USA (1979) 76:944-948.
Newman NM et al.: Acetabular bone destruc
tion related to non-steroidal anti-inflammatory drugs. Lancet
(1985) 2(8445): 11-14.
Obertreis B et al: Ex-vivo in-vitro inhibition
of lipopolysaccharide stimulated tumor necrosis factor-a and
Interleukin-1b secretion in man whole blood by extractum Urticae
dioicae foliorum. Arzneim-Forsch/Drug Res (1996)
46: 389-394.
Paulus HE et al.: Analysis of improvement
in individual rheumatoid arthritis patients treated with disease-modifying
antirheumatic drugs, based on the findings in patients treated
with placebo. Arthr Rheum (1990) 33: 477-484.
Plows D et al.: the role of tumor necrosis
factor (TNF) in arthritis: studies in transgenic mice. Rheumatol
Eur (1995) Suppl 2: 51-4.
Prashker MJ et al: the total cost of drug
therapy for rheumatoid arthritis: a model based on costs of
drug, monitoring and xicity. Arthr Rheum (1995) 38:
318-25.
Qiu GX et al.: Efficacy and safety of glucosamine
sulfate versus ibuprofen in patients with knee osteoarthritis.
Arzneim-Forsch/Drug Res (1998) 48: 469-474.
Riehemann K et al.: Plant extracts from
stinging nettle (Urtica dioica), an antirheumatic remedy,
inhibit the proinflammatory transcription factor NF-kb. FEBS
Lett (1999) 442: 89-94.
Robinson DR et al.: Lipid mediators of
inflammatory and immune reactions. J Parent Ent Nutr
(1988) 12, Suppl. S: S37-S42.
Ronningen H et al: Indomethacin treatment
in osteoarthritis of the hip joint. Acta Orthop Scand
(1979) 50: 169-74.
Saklatvala J: Tumor necrosis factor-a stimulates
resorption and inhibits synthesis of proteoglycan in cartilage.
Nature (1986) 322: 547-49.
Sharma JN et al.: Effects of eugenol and
ginger oil on adjuvant arthritis and the kallikreins in rats.
Asia Pac J Pharmacol (1997) 12: 9-14.
Sharma JN et al.: Suppressive effects of
eugenol and ginger oil on arthritic rats. Pharmacology
(1994) 49: 314-318.
Shield MJ: Anti-inflammatory drugs and
their effect on cartilage synthesis and renal function. Eur
J Rheum Inflam (1993) 13: 7-16.
Skoldstam L et al.: Effects of six months
of fish oil supplementation in stable rheumatoid arthritis:
A double-blind, controlled udy. Scand J Rheum (1992)
21: 178-185.
Solomon L: Drug induced arthropathy and
necrosis of the femoral head. J Bone Joint Surg (1973)
55B: 246-51.
Sperling RI et al.: Effects of dietary
supplementation with marine fish oil on leucocyte lipid mediator
generation and function in rheumatoid arthritis. Arthr
Rheum (1987) 30: 988-997.
Srivastava KC et al: Ginger (Zingiber-officinale)
and rheumatic disorders. Med Hypoth (1989) 29: 25-8.
Srivastava KC: Ginger (Zingiber-officinale)
in rheumatism and muscular skeletal disorders. Med Hypoth
(1992) 39: 342-348.
Uebelhart D et al.: Effects of oral chondroitin
sulfate on the progression of knee osteoarthritis: a pilot
study. Osteoarth Cartil ( 98) 6, Supplement A: 39-46.
Verbruggen G et al.: Chondroitin sulphate
S/DMOAD (structure/disease modifying anti-osteoarthritis drug)
in the treatment of finger joint OA. Osteoarth Cartil
(1998) 6, Suppl. A: 37-38.
|